ascopubs.org

Chemoimmunotherapy With a Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome–Negative Precursor B-Lineage Acute Lymphoblastic Leukemia

Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-Trans-Retinoic Acid and Anthracycline-Based Chemotherapy The prognostic relevance of immunophenotypic ...
ascopubs.org

Infusional CHOP Chemotherapy (CVAD) With or Without Chemosensitizers Offers No Advantage Over Standard CHOP Therapy in the Treatment of Lymphoma: A Southwest Oncology Group Study

Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma PURPOSE: Two phase II studies were ...
Healio

VIDEO: Evolution of hyper-CVAD in ALL

Please provide your email address to receive an email when new articles are posted on . In this video, Lori Muffly, MD, MS, discussed a presentation from the Society of Hematologic Oncology Annual ...
Healio

Adding nelarabine to hyper-CVAD appears safe, effective in adults with T-ALL

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — The addition of nelarabine to a standard hyper-CVAD regimen demonstrated durable overall response ...
Yahoo Finance

Canada Clears ABMD's Impella cVAD

Massachusetts-based heart support technologies major, Abiomed Inc. (ABMD) has received the Health Canada nod to launch its Impella cVAD heart pump. Per the approval, the Impella cVAD can be used as a ...